News

Rapiacta, licensed from US-based BioCryst Pharmaceuticals, has been developed by Shionogi in Japan. Shionogi received approval for both single dose administration for adult uncomplicated seasonal influenza infection as

The company said that its new formulation plant is likley to deliver products to over 15 countries. Pharmabiz quoted, Archana Mitra, associate vice president of exports at Bal

Reportedly, under the purchase order, Sinovac is required to deliver an additional 8.57 million doses of Panflu1 (15ug/0.5ml) to the Chinese Central Government, of which 2.33 million doses

Wockhardt will launch the product immediately upon expiration of the patent on June 20, 2011. Levofloxacin is a widely used antibacterial drug and belongs to the fluoroquinolone group,

Ofloxacin is a fluoroquinolone-based antibiotic, which addresses several indications including staph infection, strep throat (Streptococcus), pneumonia, influenza, E Coli, and several sexually transmitted bacterial diseases such as Chlamydia

GLP-1 (Glucagon-Like Peptide-1) is a natural hormone involved in controlling blood sugar levels. It stimulates the release of insulin only when blood sugar levels become too high. In

In response to the economic pressure, Lonza is strengthening its platform in Asia and will close the sites of Conshohocken (Riverside), PA (US), Shawinigan (CDN), and Wokingham (UK)

Sumavel DosePro delivers subcutaneous sumatriptan, a treatment that provides migraine relief starting within ten minutes for some patients, in a first-of-its-kind needle-free delivery system. Sumavel DosePro is expected

Octapharma said that the FDA’s approval and granting of orphan drug exclusivity of Wilate marks the entrance of the company into the US blood coagulation market, with product